• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

neu和ras引发的小鼠乳腺肿瘤具有一些遗传标记,而这些标记在由c-myc和int-2引发的肿瘤中通常不存在。

neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.

作者信息

Morrison B W, Leder P

机构信息

Department of Genetics, Harvard Medical School, Howard Hughes Medical Institute, Boston, Massachusetts 02115.

出版信息

Oncogene. 1994 Dec;9(12):3417-26.

PMID:7970700
Abstract

We have previously shown that each of four activated oncogenes (c-myc, neu, ras, and int-2) can serve as transgenic initiators of morphologically distinct adenocarcinomas of the murine mammary gland. Since abnormalities of these oncogenes are found frequently in human breast cancers, such differences are of particular interest. Thus, the distinctiveness of each murine tumor type might reflect a relationship between a specific oncogene and a susceptible target cell or might reflect distinctive changes brought about by the idiosyncratic action of each oncogene. We have identified six genes (two of them novel) expressed in tumors initiated by neu, but usually absent from tumors initiated by c-myc. The expression of these genes (kappa-casein, transferrin, cellular retinol binding protein I (CRBPI), WDNM1, and the two novel ones) cannot be induced in c-myc-initiated tumors by the introduction of an activated neu oncogene nor can their expression be inhibited in neu-initiated tumors by the introduction of c-myc. Therefore, these genes appear to represent markers of a cell type preferentially transformed by neu. Further analysis reveals that the six markers are also expressed by ras-initiated mammary tumors, but not by int-2-initiated tumors suggesting that neu/ras-initiated tumors share a common cellular lineage and/or a common signal transduction pathway. Interestingly, one of the novel marker genes (Mat-8) appears to encode a cell-surface chloride channel and the other, a secreted protein with homologies to glycosyl hydrolases, both of which might be useful for the diagnosis and treatment of specific mammary tumors.

摘要

我们之前已经表明,四种激活的癌基因(c-myc、neu、ras和int-2)中的每一种都可以作为转基因引发剂,引发形态上不同的小鼠乳腺腺癌。由于这些癌基因的异常在人类乳腺癌中经常被发现,所以这种差异特别令人感兴趣。因此,每种小鼠肿瘤类型的独特性可能反映了特定癌基因与易感靶细胞之间的关系,或者可能反映了每种癌基因的特异作用所带来的独特变化。我们已经鉴定出六个在由neu引发的肿瘤中表达,但在由c-myc引发的肿瘤中通常不存在的基因(其中两个是新基因)。这些基因(κ-酪蛋白、转铁蛋白、细胞视黄醇结合蛋白I(CRBPI)、WDNM1和两个新基因)的表达在c-myc引发的肿瘤中不能通过引入激活的neu癌基因来诱导,在neu引发的肿瘤中也不能通过引入c-myc来抑制。因此,这些基因似乎代表了一种优先被neu转化的细胞类型的标志物。进一步分析表明,这六个标志物在由ras引发的乳腺肿瘤中也有表达,但在由int-2引发的肿瘤中没有表达,这表明由neu/ras引发的肿瘤具有共同的细胞谱系和/或共同的信号转导途径。有趣的是,其中一个新的标志物基因(Mat-8)似乎编码一种细胞表面氯离子通道,另一个编码一种与糖基水解酶具有同源性的分泌蛋白,这两者都可能对特定乳腺肿瘤的诊断和治疗有用。

相似文献

1
neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.neu和ras引发的小鼠乳腺肿瘤具有一些遗传标记,而这些标记在由c-myc和int-2引发的肿瘤中通常不存在。
Oncogene. 1994 Dec;9(12):3417-26.
2
Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.响应特定癌基因时,乳腺致癌作用所激活并需要的信号转导通路。
Oncogene. 1998 Feb 12;16(6):737-46. doi: 10.1038/sj.onc.1201829.
3
Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu.蛋白质酪氨酸磷酸酶ε。一种在由v-Ha-ras或neu引发的小鼠乳腺肿瘤中特异性表达的同种型。
J Biol Chem. 1995 Nov 3;270(44):26116-22. doi: 10.1074/jbc.270.44.26116.
4
Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.转化生长因子α与c-myc在小鼠乳腺和唾液腺肿瘤发生中的协同相互作用。
Cell Growth Differ. 1995 Jun;6(6):737-48.
5
Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.ENU1564大鼠乳腺肿瘤模型中潜在致癌基因改变的评估。
Anticancer Res. 1994 Mar-Apr;14(2A):481-7.
6
T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells.T1是一种免疫球蛋白超家族成员,在乳腺细胞的H-ras依赖性上皮肿瘤中表达。
Oncogene. 1993 Mar;8(3):609-17.
7
The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.钙调蛋白激酶Pnck在小鼠乳腺发育过程中受到时空调控,可能识别出参与乳腺癌的一种上皮细胞亚型。
Cancer Res. 2000 Oct 1;60(19):5571-7.
8
Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.Ha-ras和v-raf癌基因,但不是int-2和c-myc,会干扰乳腺特异性转录因子的催乳激素依赖性激活。
Cell Growth Differ. 1993 Jan;4(1):9-15.
9
Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.角质形成细胞生长因子可诱导转基因小鼠发生乳腺和前列腺增生以及乳腺腺癌。
Oncogene. 1996 Dec 19;13(12):2507-15.
10
Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.在原发性人类乳腺癌中,与c-myc和c-erbB-2/neu扩增相比,Int-2/FGF3扩增是复发更好的独立预测指标。
Mod Pathol. 1994 Dec;7(9):900-5.

引用本文的文献

1
FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes.FXYD3 通过在角质细胞中竞争结合 TRAF3 增强 IL-17A 信号传导以促进银屑病。
Cell Mol Immunol. 2023 Mar;20(3):292-304. doi: 10.1038/s41423-023-00973-7. Epub 2023 Jan 25.
2
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial.PD-1 抑制剂(拓益)联合化疗新辅助治疗 II-III 期 NSCLC 的安全性和有效性(LungMate 002):一项开放标签、单臂、Ⅱ期临床试验。
BMC Med. 2022 Dec 30;20(1):493. doi: 10.1186/s12916-022-02696-4.
3
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1.
细胞毒性颗粒机制的瘫痪是一种新的癌症免疫逃避机制,由几丁质酶 3 样蛋白 1 介导。
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003224.
4
CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.CHI3L1 调节 PD-L1,抗 CHI3L1-PD-1 抗体引发协同抗肿瘤反应。
J Clin Invest. 2021 Nov 1;131(21). doi: 10.1172/JCI137750.
5
Promising potential of [Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy-a preclinical study using a syngeneic breast cancer model.[Lu]Lu-DOTA-叶酸增强肿瘤免疫治疗反应的潜力——使用同源乳腺癌模型的临床前研究。
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):984-994. doi: 10.1007/s00259-020-05054-9. Epub 2020 Oct 19.
6
Chitinase 3-Like 1 Contributes to Food Allergy via M2 Macrophage Polarization.几丁质酶3样蛋白1通过M2巨噬细胞极化促进食物过敏。
Allergy Asthma Immunol Res. 2020 Nov;12(6):1012-1028. doi: 10.4168/aair.2020.12.6.1012.
7
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells.前列腺癌患者循环中的单核细胞促进上皮细胞的侵袭和迁移。
Cancer Med. 2018 Sep;7(9):4639-4649. doi: 10.1002/cam4.1695. Epub 2018 Aug 9.
8
Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma.钠钾ATP酶调节因子FXYD3在人类肝细胞癌中的预后意义
Oncol Lett. 2018 Mar;15(3):3024-3030. doi: 10.3892/ol.2017.7688. Epub 2017 Dec 21.
9
The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review.YKL-40蛋白是慢性阻塞性肺疾病的潜在生物标志物:一项荟萃分析与系统评价。
Int J Chron Obstruct Pulmon Dis. 2018 Jan 30;13:409-418. doi: 10.2147/COPD.S152655. eCollection 2018.
10
New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma.浅析几丁质酶 3 样蛋白 1 与哮喘的关系
Curr Allergy Asthma Rep. 2016 Aug;16(8):57. doi: 10.1007/s11882-016-0637-2.